LIG4 Antibody

1. Cells doubly deficient in Pol theta; and Lig4 exhibit 100% gene-targeting efficiency because of virtually no random integration events. PMID: 28695890
2. These studies provide a scaffold for defining impacts of LigIV catalytic core mutations and deficiencies in human LIG4 syndrome. PMID: 29980672
3. study demonstrated that there was an association between DNA ligase 4 Thr9Ile polymorphism and male infertility and suggests CT genotype as a risk factor for male infertility PMID: 28991497
4. An increased frequency of binucleated lymphocytes with micronuclei was increased in carriers of the T/T genotype of the LIG4 (rs1805388) gene compared to miners harbouring the C/T genotype. PMID: 28992182
5. Cellular NHEJ of diverse ends thus identifies the steps necessary for repair through LIG4-mediated sensing of differences in end structure and consequent dynamic remodeling of aligned ends. PMID: 28930678
6. This study shown that both ligase IV and XRCC4 may act in concert to modulate the development of glioma. PMID: 27508978
7. We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ ERCC1]) and subsequent CNS tumors in survivors of childhood cancer treated by radiation therapy. PMID: 28976792
8. In a recombinant PNKP-XRCC4-LigIV complex, both the PNKP FHA and catalytic domains contact the XRCC4 coiled-coil and LigIV BRCT repeats. Multipoint contacts between PNKP and XRCC4-LigIV regulate PNKP recruitment and activity within NHEJ. PMID: 28453785
9. Data suggest that stimulation of Artemis nuclease/DCLRE1C activity by XRCC4-DNA ligase IV hetero-complex and efficiency of blunt-end ligation are determined by structural configurations at the DNA ends. (XRCC4 = X-ray repair cross complementing 4) PMID: 28696258
10. found that the rs228593, rs2267437 and rs1805388 functional polymorphisms probably alter the level of expression of the ATM, XRCC6 and LIG4 genes, respectively, being important in the maintenance of genomic instability in MDS PMID: 27497341
11. marked overlap of dyskeratosis congenita with four other genetic syndromes, confounding accurate diagnosis and subsequent management. Patients with clinical features of dyskeratosis congenita need to have genetic analysis of USB1, LIG4 and GRHL2 in addition to the classical dyskeratosis congenita genes and telomere length measurements. PMID: 27612988
12. The rs1805388 in LIG4 was associated with increased radioresistance. PMID: 26974709
13. LIG4 is highly upregulated in human colorectal cancer cells. PMID: 27009971
14. Five novel mutations in LIG4 and a potential hotspot mutation (c.833G > T; p.R278L) in the Chinese population with LIG4 deficiency syndrome were identified. PMID: 26762768
15. Our study identifies LIG4 as a predictor of an increased risk for early biochemical recurrence in prostate cancer PMID: 26134445
16. The genetic polymorphisms in LIG4 rs1805388 and HSPB1 rs2868371 were not obviously correlated with the risk of radiation pneumonitis and radiation-induced lung injury of lung cancer. PMID: 25811031
17. our results suggest that LIG4 rs10131 polymorphism in the DNA repair pathways plays an important role in the risk of glioma in a Chinese population. PMID: 25973104
18. Our data showed that Cd altered the phosphorylation of DNA-PKcs, and reduced the expression of both XRCC4 and Ligase IV in irradiated cells. PMID: 26201248
19. despite several limitations, this meta-analysis suggested that LIG4 T9I genetic variant is associated with a decreased risk of cancer among Caucasians, however, the rs1805386 gene polymorphism is not a risk factor of cancer. PMID: 25314918
20. High LIG4 expression is associated with less radiosensitivity of nasopharyngeal cancer. PMID: 25605214
21. DNA Ligase IV is required for efficient localization of XRCC4 and XLF into cell nucleus. PMID: 24984242
22. Ku-independent, LIGIV-dependent repair pathway exists in human somatic cells. PMID: 24837021
23. LIG4 Thr9Ile polymorphism is associated with treatment response in advanced non-small cell lung cancer. PMID: 24722796
24. Our data did not show association between LIG4 and RAD52 SNPs and SLE, its clinical manifestations or ethnicity in the tested population. PMID: 24415301
25. Loss of LIG4 is associated with colorectal cancer. PMID: 24282031
26. Results show that in cells deficient for Lig4, chromosomal translocations junctions had significantly longer deletions and more microhomologies. PMID: 25201414
27. Characterization of the protein interaction domains that modulate the XRCC4/Ligase IV interaction. PMID: 23794378
28. study reports the identification of biallelic truncating LIG4 mutations in 11 patients with microcephalic primordial dwarfism presenting with restricted prenatal growth and extreme postnatal global growth failure PMID: 24123394
29. DNA ligase IV expression of K562/DNR was also suppressed significantly with Sp1 family protein inhibition PMID: 24530422
30. DNA ligase IV and Artemis act cooperatively to promote nonhomologous end-joining PMID: 23967291
31. These results indicate for the first time that LIG4 rs1805388 and X-ray Repair Cross Complementing-4 (XRCC4) rs1805377, alone or in combination, are associated with a risk of gliomas. PMID: 23663450
32. The chromatin binding of XRCC4 was dependent on the presence of LIG4. PMID: 23994631
33. genetic association studies in population in China: Data suggest that SNPs in LIG4 (rs1805388, exon 2 54C>T, Thr9Ile) and RAG1 (recombination activating gene 1, rs2227973, A>G, K820R) are associated with male infertility. PMID: 23630330
34. No association between LIG4 gene polymorphisms (rs1805386 T>C, rs1805389 C>T, rs1805388 C>T and rs2232641 A>G) and breast cancer risk. PMID: 22994770
35. Structural basis of DNA ligase IV-Artemis interaction in nonhomologous end-joining. PMID: 23219551
36. DNA Ligase IV is differentially required for certain chromosome fusion events induced by telomere dysfunction. PMID: 23275564
37. The flexibility of the DNA ligase IV catalytic region is limited in a manner that affects the formation of the LigIV/XRCC4/XLF-Cernunnos complex. PMID: 22658747
38. The alpha2 helix in the Lig4 BRCT-1 domain is required for adenovirus-mediated degradation of Lig4. PMID: 22534089
39. polymorphisms in LIG4 do not contribute to cancer risk in a population of Lynch syndrome patients with colorectal cancer PMID: 21974800
40. XRCC4 modulates the dynamic interaction of the Ligase IV/XRCC4 complex with the NHEJ machinery at double-stranded DNA breaks PMID: 21982441
41. The current results indicated that NHEJ genetic polymorphisms, particularly LIG4 rs1805388, may modulate the risk of RP in patients with NSCLC who receive definitive radio(chemo)therapy PMID: 21717429
42. these results suggest that some variants in XRCC4, LIG4 and Ku80 genes can contribute to thyroid cancer susceptibility PMID: 20811692
43. in the Chinese population, LIG4 Ile658Val has only a slight impact on the risk of developing cervical carcinoma PMID: 20400235
44. Polymorphisms in the LIG4, BTBD2, HMGA2, and RTEL1 genes, which are involved in the double-strand break repair pathway, are associated with glioblastoma multiforme survival. PMID: 20368557
45. role of NHEJ enzyme Ligase IV in the pathogenesis of MDS PMID: 19727724
46. provide a first sight of the structural organization of the Lig4-Xrcc4 complex, which suggests that the BRCT domains could provide the link of the ligase to Xrcc4 while permitting some movements of the catalytic domains of Lig4. PMID: 19837014
47. crystal structure of an Xrcc4-DNA ligase IV complex PMID: 11702069
48. mutations identified in patients exhibiting developmental delay and immunodeficiency PMID: 11779494
49. Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. PMID: 12077346
50. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination PMID: 12471202

Show More

Hide All

HGNC: 6601

OMIM: 601837

KEGG: hsa:3981

STRING: 9606.ENSP00000349393

UniGene: Hs.166091